This is a working overview of research chemical, written for readers who want more than a one-paragraph summary but less than a textbook.
Reviewed 2025-09-10. Anything still debated is marked as such rather than presented as settled.
The sequence contains an unusually high proportion of proline and glycine, which limits regular secondary structure and contributes to solubility in aqueous media. The compound dissolves readily in water and in normal saline. Because it is a peptide, digestive enzymes are expected to break it down if it is swallowed, a consideration that influences the routes of administration used in animal experiments. Detailed conformational data remain limited, and published structural models are largely computational.
BPC 157 is a synthetic peptide built from fifteen amino acids. The letters stand for body protection compound, and the number is a laboratory code rather than a description of any biological feature. Its single-letter sequence is GEPPPGKPADDAGLV, which corresponds to a calculated mass near 1419.5 daltons. The material is produced by solid-phase peptide synthesis and is distributed as a lyophilized powder, not as a purified extract from a natural source.
Early work on this family of molecules examined fractions of human gastric juice, where a larger protein was reported to protect gastrointestinal tissue in animal models. BPC 157 was designed as a shorter, more stable fragment of that protein and then studied on its own. The peptide itself is not a normal dietary component and is not present in the human body in meaningful quantities. Descriptions of its origin therefore refer to the research lineage of a laboratory molecule rather than to an endogenous or nutritional substance.
Published work on BPC-157 spans several decades and covers a wide range of experimental models. Much of the early literature reports outcomes in animal studies involving induced injury to the gastrointestinal tract, tendons, and other tissues. The volume of preclinical reports is large, while controlled human trials remain scarce. This imbalance is a recurring point of discussion, because animal findings do not automatically translate into human effects. Reviews often note that study designs differ substantially across laboratories.
Interest in the peptide has grown through online communities that discuss self-administered use, which sits outside formal research settings. Regulatory status varies by country, and in many jurisdictions the compound is not approved as a therapeutic product. Questions about optimal routes of administration, long-term effects, and dose-response relationships remain open. Published pharmacokinetic data in humans are limited, and much of what circulates in popular discussion is extrapolated from animal work rather than measured directly in people.
| Property | Value | Notes |
|---|---|---|
| Molecular weight | About 1419.5 Da | Calculated from the fifteen-residue sequence |
| Residue count | 15 amino acids | Single-letter sequence GEPPPGKPADDAGLV |
| Compound class | Synthetic peptide | Produced by solid-phase synthesis |
| Synonyms | BPC 157; pentadecapeptide BPC 157 | Naming varies across suppliers and papers |
| Appearance | White to off-white powder | Typical form of the lyophilized material |
Terminology in the literature is not fully standardised. Papers and product listings use BPC-157, BPC 157, and the longer phrase stable gastric pentadecapeptide BPC 157 interchangeably, and synonyms such as bepecin or PL 14736 appear in older or company-linked publications. Purity claims and reported masses can also differ between sources because peptide preparations may include counterions, residual solvents, or bound water. This variability complicates direct comparison of results across studies and makes the exact identity and grade of a given sample worth verifying. Discussions of the compound should therefore specify the source, salt form, and stated purity where those are known.
BPC-157 is a synthetic peptide composed of fifteen amino acid residues, with the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. Its name derives from body protection compound, a term used for a protein fraction identified in human gastric juice. Researchers in Zagreb first reported the pentadecapeptide in the early 1990s and described it as a stable fragment of that larger protein. The compound is also catalogued as PL 14736 and, in some commercial contexts, as bepecin. Its molecular formula is C62H98N16O22 and its monoisotopic mass is approximately 1419 daltons.
Outside laboratory supply channels, the peptide is sold as a research chemical, a category that carries no requirement to demonstrate purity, identity, or freedom from contamination. Because it is not an approved medicine, products labeled BPC-157 sit in a regulatory gap in many countries, and actual content may differ from the label. Sports organizations list it among prohibited substances, so its presence in an athlete's sample can produce a doping finding regardless of how the material was obtained.
BPC-157 is a synthetic peptide of fifteen amino acids, written as GEPPPGKPADDAGLV, whose sequence matches part of a larger protein identified in human gastric juice. That parent protein was described in stomach-secretion research, and the fifteen-residue fragment was named body protection compound, which gives the peptide its common label. Material used in experiments is produced by solid-phase peptide synthesis rather than extracted from tissue. The reported molecular weight is about 1419 daltons, and the chain contains several proline residues, a feature that appears in discussions of its resistance to enzymatic breakdown.
A blood test is a laboratory analysis performed on a blood sample that is usually extracted from a vein in the arm using a hypodermic needle, or via fingerprick. Multiple tests for specific blood components, such as a glucose test or a cholesterol test, are often grouped together into one test panel called a blood panel or blood work. Blood tests are often used in health care to determine physiological and biochemical states, such as disease, mineral content, pharmaceutical drug effectiveness, and organ function. Typical clinical blood panels include a basic metabolic panel or a complete blood count. Blood tests are also used in drug tests to detect drug abuse.
==== Maturation and export ==== The localization of some of the Pvd proteins in the periplasm and the outer membrane (such as PvdN, PvdO, PvdP, and PvdQ) have been interpreted to suggest that portions of the maturation of pyoverdine takes place in this location, perhaps after being transported into the periplasm by PvdE, which is homologous to ABC type exporters. How completely matured pyoverdine is exported from the cell remains unclear. Once completely matured, pyoverdine is exported from the periplasm by PvdRT-OpmQ efflux pump.
=== Immune regulation === ITGA1 is expressed on multiple immune cell populations, including T cells, natural killer T (NKT) cells, and natural killer (NK) cells. It contributes to innate and adaptive immune responses by regulating immune cell adhesion, migration, tissue retention, inflammatory signaling, cell growth, and differentiation. In human decidual NK (dNK) cells, ITGA1 regulates adhesion, migration, and cytotoxic activity. Blocking CD49a (aka ITGA1) limits dNK migration and adhesion while increasing expression of cytotoxic molecules such as perforin, granzyme B, and interferon-γ, indicating that ITGA1 maintains the specialized immune-regulatory phenotype of dNK cells during pregnancy. ITGA1 also contributes to immune cell retention and tissue maintenance through collagen-dependent signaling. Collagen binding activates pathways that promote immune cell proliferation and inflammatory cytokine secretion and may regulate angiogenic responses through increased ITGA1 expression on endothelial and mesangial cells.
==== Platelet-type ==== Platelet-type VWD (also known as pseudo-VWD) is an autosomal dominant genetic defect of the platelets. The VWF is qualitatively normal and genetic testing of the von Willebrand gene and VWF protein reveals no mutational alteration. The defect lies in the qualitatively altered GPIb receptor on the platelet membrane which increases its affinity to bind to the VWF. Large platelet aggregates and high molecular weight VWF multimers are removed from the circulation resulting in thrombocytopenia and diminished or absent large VWF multimers. The ristocetin cofactor activity and loss of large VWF multimers are similar to VWD type 2B.
Sources: en.wikipedia.org
The wound-healing process is not only complex but fragile, and it is susceptible to interruption or failure leading to the formation of non-healing chronic wounds. Factors that contribute to non-healing chronic wounds are diabetes, venous or arterial disease, infection, and metabolic deficiencies of old age. Wound care encourages and speeds wound healing via cleaning and protection from reinjury or infection. Depending on each patient's needs, it can range from the simplest first aid to entire nursing specialties such as wound, ostomy, and continence nursing and burn center care.
Thorium is still used as an alloying element in TIG welding electrodes but is slowly being replaced in the field with different compositions. It was also material in high-end optics and scientific instrumentation, used in some broadcast vacuum tubes, and as the light source in gas mantles, but these uses have become marginal. It has been suggested as a replacement for uranium as nuclear fuel in nuclear reactors, and several thorium reactors have been built. Thorium is also used in strengthening magnesium, coating tungsten wire in electrical and welding equipment, controlling the grain size of tungsten in electric lamps, high-temperature crucibles, and glasses including camera and scientific instrument lenses. Other uses for thorium include heat-resistant ceramics, aircraft engines, and in light bulbs. Ocean science has used 231Pa/230Th isotope ratios to understand the ancient ocean.
=== Brand names === As of 2018, the combination is marketed under several brand names, including Efficib, Janmet, Januet, Janumet, Jznumet, Ristaben Met, Ristfor, Siglimet, Sitamet, Sitar-M, Sliptin-M, Treviamet, Velmetia, Istamet, Emsita, Sitaglyn, Sitazit-M, and Zaxoran.
According to Ahmed Addaghashi, a professor at Sanaa University, the Houthis began as a moderate theological movement that preached tolerance and held a broad-minded view of all the Yemeni peoples. Their first organization, "the Believing Youth" (BY), was founded in 1992 in Saada Governorate by either Mohammed al-Houthi, or his brother Hussein al-Houthi. The Believing Youth established school clubs and summer camps in order to "promote a Zaydi revival" in Saada. By 1994–95, between 15,000 and 20,000 students had attended BY summer camps. The religious material included lectures by Mohammed Hussein Fadhlallah (a Lebanese Shia scholar) and Hassan Nasrallah (Secretary General of Hezbollah). The formation of the Houthi organisations has been described by Adam Baron of the European Council on Foreign Relations as a reaction to foreign intervention. Their views include shoring up Zaydi support against the perceived threat of Saudi-influenced ideologies in Yemen and a general condemnation of the former Yemeni government's alliance with the United States, which, along with complaints regarding the government's corruption and the marginalisation of much of the Houthis' home areas in Saada, constituted the group's key grievances. Although Hussein al-Houthi, who was killed in 2004, had no official relation with Believing Youth (BY), according to Zaid, he contributed to the radicalisation of some Zaydis after the 2003 invasion of Iraq. BY-affiliated youth adopted anti-American and anti-Israel slogans, which they chanted in the Al Saleh Mosque in Sanaa after Friday prayers.
He also founded the Collective Investigation Record for the British Medical Association; this organization collected data from physicians practicing outside the hospital setting and was the precursor of modern collaborative clinical trials."
Sources: en.wikipedia.org
=== Deaths === Combined consumption of U-47700 with fentanyl and flubromazepam caused one fatality each in Belgium and Germany, respectively. One death was reported in Ireland and another one in Italy. 17 opioid overdoses and several deaths in the United States had initially been associated with U-47700 in April 2016. As of September 2016 at least 15 fatalities were confirmed. By December 2017, at least 46 fatalities had been associated with the use of U-47700. U-47700 was found in combination with fentanyl during the autopsy of the American artist Prince in 2016.
A refrigerated container or reefer is an intermodal container (shipping container) used in intermodal freight transport that is capable of refrigeration for the transportation of temperature-sensitive, perishable cargo. These containers are a critical component of the cold chain, the supply chain that preserves goods like fruits, vegetables, meat, and pharmaceuticals at a specific low temperature. While a reefer has an integral refrigeration unit, it relies on external power from electrical power points (“reefer points”) at a land-based site, a container ship, or on a quay. When being transported over the road on a trailer or over a rail wagon, it can be powered from a diesel-powered generator ("gen set") that attaches to the container during road journeys. Refrigerated containers are capable of maintaining a constant internal temperature ranging from −65 °C (−85 °F) up to 40 °C (104 °F). The market for cold chain tracking solutions is growing rapidly, driven by the increasing global demand for fresh food and temperature-sensitive pharmaceuticals. The number of active tracking devices for refrigerated containers is projected to grow significantly, highlighting the increasing importance of this technology for ensuring food safety and product integrity. The impact on society of reefer containers is vast, allowing consumers all over the world to enjoy fresh produce at any time of year.
An increasingly popular trend is to freeze-dry the animal. For all intents and purposes, a freeze-dried mount is a mummified animal. The internal organs are removed during preparation; however, all other tissue remains in the body. (The skeleton and all accompanying musculature is still beneath the surface of the skin) The animal is positioned into the desired pose, then placed into the chamber of a special freeze-drying machine designed specifically for this application. The machine freezes the animal and also creates a vacuum in the chamber. Pressure in the chamber helps vaporize moisture in the animal's body, allowing it to dry out. The rate of drying depends on vapor pressure. (The higher the pressure, the faster the specimen dries.) Vapor pressure is determined by the temperature of the chamber; the higher the temperature, the higher the vapor pressure is at a given vacuum. The length of the dry-time is important because rapid freezing creates less tissue distortion (i.e.; shrinkage, warping, and wrinkling) The process can be done with reptiles, birds, and small mammals such as cats, rodents, and some dogs. Large specimens may require up to six months in the freeze dryer before they are completely dry. Freeze-drying is the most popular type of pet preservation. This is because it is the least invasive in terms of what is done to the animal's body after death, which is a concern of owners (Most owners do not opt for a traditional skin mount).
== Career == Zaffaroni joined Syntex, then a small chemical company in Mexico, as a biochemist in 1951. He participated in turning Syntex into a major multinational pharmaceutical company, moving it to Palo Alto, California. He was appointed president of the U.S. subsidiary in 1962. In 1968, he founded ALZA, a syllabic abbreviation of his name, to develop medical treatments through controlled drug delivery. He modeled new delivery systems after the processes discovered in endocrinology – where glands deliver very small amounts of hormones but have a tremendous effect –. ALZA's first controlled drug delivery product was used to treat glaucoma. Other products that incorporated Zaffaroni's drug delivery technologies include Glucotrol, for non insulin-dependent diabetes; Duragesic, for management of severe chronic pain; NicoDerm CQ, for smoking cessation; and Transderm-Scop, to prevent nausea and vomiting associated with motion sickness. In 1980, Zaffaroni established DNAX, a developer of macromolecular products that combines the technologies of genetic engineering and immunobiology. In 1988 he co-founded Affymax, specializing in combinatorial chemistry to reduce the cost and time of identifying new medicines. In 1991 he co-founded Affymetrix, specializing in using genetics for developing new medicine. He was also involved in the creation of Perlegen Sciences, an Affymetrix spin-off which works on finding genetic causes of disease. In 1994, he founded Symyx Technologies, a company dedicated to utilizing combinatorial chemistry technologies.
The neurotransmitter serotonin, a non-selective serotonin receptor agonist, strongly increases oxytocin levels, by up to 12-fold, when given via intracerebroventricular injection in rodents. This can be blocked by various serotonin receptor antagonists. Selective serotonin 5-HT1A receptor agonists like 8-OH-DPAT, buspirone, and ipsapirone increase oxytocin levels in rodents. Both 8-OH-DPAT and buspirone maximally increased oxytocin levels by around 9-fold, whereas ipsapirone increased oxytocin levels by only around 3-fold. Similarly to serotonin 5-HT1A receptor agonists, the serotonin 5-HT2 receptor agonist DOI increases oxytocin levels in rodents, with a maximal increase of around 5- to 10-fold depending on the dose. The serotonin 5-HT2A receptor antagonist ketanserin reduced the increase in oxytocin levels induced by DOI by about 90%, while addition of the serotonin 5-HT2A, 5-HT2B, and 5-HT2C receptor antagonist LY-53857 fully blocked the increase. The non-selective but preferential serotonin 5-HT2C receptor agonist meta-chlorophenylpiperazine (mCPP) maximally increased oxytocin levels by around 6-fold, with the increases minimally affected by ketanserin but abolished by non-selective serotonin 5-HT2 receptor antagonists including LY-53857, mianserin, and metergoline. Another non-selective but preferential serotonin 5-HT2C receptor agonist, MK-212, robustly increases oxytocin levels in rodents as well. The serotonin 5-HT3 receptor agonists SR-57277 and m-CPBG and the serotonin 5-HT4 receptor agonist RS-67506 increase oxytocin levels maximally by several-fold in rodents.
Sources: en.wikipedia.org
It is a synthetic peptide. Its design was inspired by a fragment of a protein found in human gastric juice, but the fifteen-amino-acid molecule itself is made in a laboratory and is not a normal component of food or of human tissue in appreciable amounts.
The number is an internal laboratory designation from the research group that first described the fragment. It does not encode a molecular weight, a receptor target, or a measured biological effect, and it carries no meaning outside the naming history of the compound.
It contains fifteen amino acid residues and has a calculated mass of roughly 1419.5 daltons. That places it in the short-peptide range, well below the size of small proteins, which affects how it is synthesized, purified, and analyzed.
It is a synthetic peptide of fifteen amino acids whose sequence matches a fragment of a protein found in human gastric juice. It is studied mainly in laboratory and animal research rather than as an approved medicine.